Insider Trading History of Bleil Lynn Dorsey

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Bleil Lynn Dorsey since 2016. This trader's CIK number is 1607309. At the time of last reporting, Bleil Lynn Dorsey was the Director of Amicus Therapeutics, Inc.. (stock ticker symbol FOLD). Also see all insider trading activities at Amicus Therapeutics, Inc..

Note that in the past Bleil Lynn Dorsey also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stericycle Inc (SRCL) by Bleil Lynn Dorsey

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 SRCL 0 $0 0 $0 1,970 $0
2017 SRCL 0 $0 0 $0 495 $0

Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Bleil Lynn Dorsey

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 FOLD 28,605 $250,007 0 $0 0 $0

Yearly summary of insider trading at Dst Systems Inc (DST) by Bleil Lynn Dorsey

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 DST 1,500 $149,250 0 $0 0 $0


Insider trading activities at 3 companies by Bleil Lynn Dorsey:

1. Stericycle Inc (SRCL)

2. Amicus Therapeutics, Inc. (FOLD)

3. Dst Systems Inc (DST)

Table 1. Insider trading of Stericycle Inc (SRCL) by Bleil Lynn Dorsey

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-23 SRCL Option Ex 1,970 .00 0
2017-05-25 SRCL Option Ex 495 .00 0

Table 2. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Bleil Lynn Dorsey

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-05-25 FOLD Buy 28,605 8.74 250,007

Table 3. Insider trading of Dst Systems Inc (DST) by Bleil Lynn Dorsey

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-02-11 DST Buy 1,500 99.50 149,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bleil Lynn Dorsey (Director of Amicus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.